BiomericaBMRA
Market Cap: $5.84M
About: Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
Employees: 64
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
5% less funds holding
Funds holding: 37 [Q1] → 35 (-2) [Q2]
9.06% less ownership
Funds ownership: 22.3% [Q1] → 13.24% (-9.06%) [Q2]
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
69% less capital invested
Capital invested by funds: $3.12M [Q1] → $982K (-$2.14M) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for BMRA.